Pathophysiology and Pharmacology of Chronic Myeloid Leukemia

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorRonen, Shira
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intenzív Terápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2014-11-18T10:30:21Z
dc.date.available2014-11-18T10:30:21Z
dc.date.created2014-10-10
dc.description.abstractChronic myelogenous leukemia is a hematopoietic stem cell tumor that accounts for 15% - 20% of all leukemia cases. Diagnosis of the disease is by physical exam, complete blood counts, peripheral blood smear, bone marrow aspiration, cytochemistry, imaging and genetic analysis. The final diagnosis of CML is performed by finding the genetic translocation, t(9;22), the Philadelphia Chromosome (Ph) which form a BCR-ABL fusion oncogen. A new biological treatment that inhibits this chromosome, BCR-ABL tyrosine kinase inhibitors (TKIs), alters the outcome of CML patients from one with shortened life expectancy to a long-term survival. New generation of TKIs were introduced in the last few years, including nilotinib, dasatinib, bosutinib, and ponatinib; all which have a better and faster responses. Many clinical trials are still ongoing and we are eagerly awaiting results. Epidemiology, the Philadelphia chromosome, clinical phases, monitoring techniques, and treatments (including TKIs, chemotherapy, interferon alpha, and stem cell transplantation) of CML are reviewed in my thesis.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeMSc/MAhu_HU
dc.format.extent34 pageshu_HU
dc.identifier.urihttp://hdl.handle.net/2437/200839
dc.language.isoenhu_HU
dc.subjectPathophysiology and Pharmacology of Chronic Myeloid Leukemiahu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titlePathophysiology and Pharmacology of Chronic Myeloid Leukemiahu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)